AN UPDATED REVIEW ON: FLOATING DRUG DELIVERY SYSTEM (FDDS)

Recent technological and scientific research has been devoted to the development of rate controlled drug delivery systems to overcome physiological adversities such as short gastric residence times and unpredictable gastric emptying times. Differences in gastric physiology such as gastric pH and motility exhibit both intra and inter subject variability demonstrating significant impact on gastric residence time and drug delivery behavior. This triggered an increased interest towards formulation of novel delivery systems which retained in the stomach for prolonged and predictable period of time. Several approaches such as floating drug delivery systems (FDDS), swelling and expanding systems, bioadhesive systems, modified shape systems, high density systems or other delayed gastric emptying devices have been discovered till now. FDDS are of particular interest for drugs that are locally active and have narrow absorption window in stomach or upper small intestine, unstable in the intestinal or colonic environment, and exhibit low solubility at high pH values. This review article is in pursuit of giving detailed information on the pharmaceutical basis of their design, classification, advantages, in vitro and in vivo evaluation parameters, and the future potential of FDDS.

[1]  P. Dallas,et al.  FLOATING AND SWELLING CHARACTERISTICS OF VARIOUS EXCIPIENTS USED IN CONTROLLED RELEASE TECHNOLOGY , 1993 .

[2]  R. Garg,et al.  Gastroretentive Floating Microspheres of Silymarin: Preparation and In Vitro Evaluation , 2010 .

[3]  Arvind K. Bansal,et al.  A Means to Address Regional Variability in Intestinal Drug Absorption , 2003 .

[4]  Parviz Mojaverian,et al.  Effects of Gender, Posture, and Age on Gastric Residence Time of an Indigestible Solid: Pharmaceutical Considerations , 1988, Pharmaceutical Research.

[5]  F. N. Christensen,et al.  The effect of density on the gastric emptying of single- and multiple-unit dosage forms , 1986, Pharmaceutical Research.

[6]  J. Newton,et al.  The influence of density on the gastrointestinal transit of pellets , 1990, The Journal of pharmacy and pharmacology.

[7]  Saurabh Wadhwa,et al.  Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation. , 2005, Acta pharmaceutica.

[8]  Javed Ali,et al.  Floating drug delivery systems: A review , 2005, AAPS PharmSciTech.

[9]  P. Gupta,et al.  Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.

[10]  P. S. Naruka,et al.  Development and evaluation of floating microspheres of verapamil hydrochloride , 2007 .

[11]  Av Mayavanshi,et al.  Floating drug delivery systems to increase gastric retention of drugs: A Review , 2008 .

[12]  Y. Kawashima,et al.  Hollow microspheres for use as a floating controlled drug delivery system in the stomach. , 1992, Journal of pharmaceutical sciences.

[13]  Clive G. Wilson,et al.  Physiological pharmaceutics : biological barriers to drug absorption , 1989 .

[14]  V. Iannuccelli,et al.  Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation , 1998 .

[15]  J. Timmermans,et al.  The Bilayer Floating Capsule: A Stomach-Directed Drug Delivery System for Misoprostol , 1992, Pharmaceutical Research.

[16]  Blum Al,et al.  The effect of specific gravity and eating on gastric emptying of slow-release capsules. , 1981 .

[17]  J. Timmermans,et al.  Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. , 1994, Journal of pharmaceutical sciences.

[18]  J Kristl,et al.  Optimisation of floating matrix tablets and evaluation of their gastric residence time. , 2000, International journal of pharmaceutics.

[19]  A. Hoffman,et al.  Furosemide Pharmacokinetics and Pharmacodynamics following Gastroretentive Dosage Form Administration to Healthy Volunteers , 2003, Journal of clinical pharmacology.

[20]  C. Gardner,et al.  Controlled Gastric Emptying. 1. Effects of Physical Properties on Gastric Residence Times of Nondisintegrating Geometric Shapes in Beagle Dogs , 1988, Pharmaceutical Research.

[21]  J H Collett,et al.  Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Shoufeng Li,et al.  Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. , 2003, International journal of pharmaceutics.

[23]  P. Maincent,et al.  Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[24]  N. Özdemir,et al.  Studies of Floating Dosage Forms of Furosemide: In Vitro and In Vivo Evaluations of Bilayer Tablet Formulations , 2000, Drug development and industrial pharmacy.

[25]  R. Gröning,et al.  Oral Dosage Forms with Controlled Gastrointestinal Transit , 1984 .

[26]  J. Timmermans,et al.  Intragastric positioning of two concurrently ingested pharmaceutical matrix dosage forms. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[27]  P. Deasy,et al.  In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate , 1992 .